Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-12 11:33 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
50,001 | |
Filed 2024-09-12 11:33 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$185,659
+16,666 vol $11.14 each |
543,448 | |
Filed 2024-09-12 11:30 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-6,666 vol |
26,668 | |
Filed 2024-09-12 11:30 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$49,060
+4,404 vol $11.14 each |
13,014 | |
Filed 2024-09-12 11:28 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-6,666 vol |
26,668 | |
Filed 2024-09-12 11:27 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$32,528
+2,920 vol $11.14 each |
32,252 | |
Filed 2024-09-12 11:21 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
46,668 | |
Filed 2024-09-12 11:20 Tx date 2024-09-10 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$81,399
+7,307 vol $11.14 each |
46,839 | |
Filed 2024-08-27 14:47 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
33,334 | |
Filed 2024-08-27 14:47 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$77,588
+6,038 vol $12.85 each |
29,332 | |
Filed 2024-08-27 14:46 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
26,667 | |
Filed 2024-08-27 14:45 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,801
+9,747 vol $11.06 each |
14,847 | |
Filed 2024-08-27 14:44 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+20,000 vol |
46,667 | |
Filed 2024-08-27 14:43 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+40,000 vol |
40,000 | |
Filed 2024-08-27 14:42 Tx date 2021-05-19 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-08-27 14:29 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
33,334 | |
Filed 2024-08-27 14:29 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$110,638
+8,610 vol $12.85 each |
8,610 | |
Filed 2024-08-27 14:28 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
26,667 | |
Filed 2024-08-27 14:27 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$96,133
+8,692 vol $11.06 each |
8,692 | |
Filed 2024-08-27 14:26 Tx date 2023-05-17 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-08-27 14:23 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+20,000 vol |
46,667 | |
Filed 2024-08-27 14:22 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+40,000 vol |
40,000 | |
Filed 2024-08-27 14:21 Tx date 2023-05-17 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-08-27 13:56 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$139,234
+12,589 vol $11.06 each |
486,336 | |
Filed 2024-08-27 13:53 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
63,334 | |
Filed 2024-08-27 13:52 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$77,588
+6,038 vol $12.85 each |
39,532 | |
Filed 2024-08-27 13:50 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-13,333 vol |
26,667 | |
Filed 2024-08-27 13:50 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$107,801
+9,747 vol $11.06 each |
33,494 | |
Filed 2024-08-27 13:48 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+50,000 vol |
76,667 | |
Filed 2024-08-27 13:46 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+40,000 vol |
40,000 | |
Filed 2024-08-27 13:44 Tx date 2024-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$125,480
+9,765 vol $12.85 each |
||
Filed 2024-08-27 13:35 Tx date 2024-05-29 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-33,334 vol |
83,334 | |
Filed 2024-08-27 13:34 Tx date 2024-05-29 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$257,050
+23,779 vol $10.81 each |
510,115 | |
Filed 2024-08-27 13:33 Tx date 2022-05-24 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-33,333 vol |
66,667 | |
Filed 2024-08-27 13:32 Tx date 2022-05-24 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$216,709
+23,893 vol $9.07 each |
436,189 | |
Filed 2024-08-27 13:31 Tx date 2023-05-24 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-33,333 vol |
83,334 | |
Filed 2024-08-27 13:30 Tx date 2023-05-24 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$427,554
+24,558 vol $17.41 each |
473,747 | |
Filed 2024-08-27 13:27 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
66,668 | |
Filed 2024-08-27 13:26 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$163,027
+12,589 vol $12.95 each |
||
Filed 2024-08-27 12:27 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-33,333 vol |
100,001 | |
Filed 2024-08-27 12:27 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-33,333 vol |
||
Filed 2024-08-27 12:26 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$318,026
+24,558 vol $12.95 each |
462,443 | |
Filed 2024-08-27 12:26 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$318,026
+24,558 vol $12.95 each |
||
Filed 2024-08-27 12:25 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
133,334 | |
Filed 2024-08-27 12:25 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
||
Filed 2024-08-27 12:24 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$219,174
+12,589 vol $17.41 each |
||
Filed 2024-08-27 12:24 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$219,174
+12,589 vol $17.41 each |
437,885 | |
Filed 2024-08-27 12:22 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
||
Filed 2024-08-27 12:22 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$219,174
+12,589 vol $17.41 each |
||
Filed 2024-08-27 12:16 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318,026
+24,558 vol $12.95 each |
||
Filed 2024-08-27 12:14 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,666 vol |
||
Filed 2024-08-27 12:12 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$219,174
+12,589 vol $17.41 each |
||
Filed 2024-08-27 12:11 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$219,174
+12,589 vol $17.41 each |
||
Filed 2024-08-27 12:06 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
-16,667 vol |
133,334 | |
Filed 2024-08-27 12:04 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,170
+16,667 vol $12.85 each |
479,110 | |
Filed 2024-08-27 11:59 Tx date 2023-09-08 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+50,000 vol |
200,000 | |
Filed 2024-08-27 11:57 Tx date 2022-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+50,000 vol |
150,000 | |
Filed 2024-08-27 11:54 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,170
+16,667 vol $12.85 each |
||
Filed 2024-08-27 11:52 Tx date 2024-08-26 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,170
+16,667 vol $12.85 each |
||
Filed 2024-08-16 13:19 Tx date 2024-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$125,480
+9,765 vol $12.85 each |
||
Filed 2024-03-27 14:15 Tx date 2023-05-17 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-12-22 10:09 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318,026
+24,558 vol $12.95 each |
||
Filed 2023-12-22 10:08 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$219,174
+12,589 vol $17.41 each |
||
Filed 2024-08-16 13:19 Tx date 2024-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$125,480
+9,765 vol $12.85 each |
33,512 | |
Filed 2024-03-27 14:25 Tx date 2024-03-26 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,099.2416
-8,692 vol $8.06 each |
0 | |
Filed 2024-03-27 14:15 Tx date 2023-05-17 |
$PRN
Profound Medical Corp. |
Goodman, Abbey Klair
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,692 | ||
Filed 2023-12-22 10:09 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$318,026
+24,558 vol $12.95 each |
462,443 | |
Filed 2023-12-22 10:08 Tx date 2023-05-21 |
$PRN
Profound Medical Corp. |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$219,174
+12,589 vol $17.41 each |
437,885 | |
Filed 2023-12-22 10:01 Tx date 2023-12-05 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$77,090
+5,447 vol $14.15 each |
13,547 | |
Filed 2023-12-22 10:00 Tx date 2023-09-26 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,988
+3,000 vol $13.66 each |
8,100 | |
Filed 2023-12-22 09:59 Tx date 2021-05-19 |
$PRN
Profound Medical Corp. |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,100 | ||
Filed 2023-12-22 09:54 Tx date 2023-08-15 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$126,223
+9,747 vol $12.95 each |
23,747 | |
Filed 2023-12-21 14:43 Tx date 2015-11-17 |
$PRN
Profound Medical Corp. |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-06-16 09:37 Tx date 2023-05-17 |
$PRN
Profound Medical Corp. |
Warnken, Hartmut
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
950 | ||
Filed 2022-12-20 16:24 Tx date 2022-12-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$101,485
+13,000 vol $7.81 each |
425,296 | |
Filed 2022-09-13 09:15 Tx date 2022-09-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,950
+5,000 vol $5.59 each |
22,700 | |
Filed 2022-06-29 14:52 Tx date 2022-06-29 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,970
+3,000 vol $6.99 each |
17,700 | |
Filed 2022-06-14 11:47 Tx date 2022-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,900
+2,500 vol $7.56 each |
14,700 | |
Filed 2022-06-02 14:14 Tx date 2022-06-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,785
+3,000 vol $8.93 each |
16,762 | |
Filed 2022-06-02 14:13 Tx date 2022-06-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,610
+500 vol $9.22 each |
13,762 | |
Filed 2022-06-02 14:13 Tx date 2022-05-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$61,426
+6,762 vol $9.08 each |
13,262 | |
Filed 2022-06-02 13:06 Tx date 2022-06-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,101
+538 vol $9.48 each |
7,038 | |
Filed 2022-05-25 10:18 Tx date 2022-05-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,550
+1,000 vol $6.55 each |
412,296 | |
Filed 2022-05-21 10:14 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,250
+2,500 vol $6.90 each |
411,296 | |
Filed 2022-05-20 15:15 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,955
+1,735 vol $8.62 each |
3,150 | |
Filed 2022-05-20 14:38 Tx date 2022-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,832
+2,400 vol $8.68 each |
6,000 | |
Filed 2022-05-20 08:25 Tx date 2022-05-13 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,340
+600 vol $8.90 each |
3,600 | |
Filed 2022-05-20 08:25 Tx date 2021-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,196
+3,000 vol $18.73 each |
3,000 | |
Filed 2022-05-20 08:24 Tx date 2021-03-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-05-18 13:20 Tx date 2022-05-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,800
+4,000 vol $8.95 each |
14,000 | |
Filed 2022-05-16 10:19 Tx date 2022-05-13 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$207,705
+30,000 vol $6.92 each |
408,796 | |
Filed 2022-05-13 13:13 Tx date 2022-05-12 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$203,077
+30,516 vol $6.65 each |
378,796 | |
Filed 2022-05-13 13:10 Tx date 2022-05-12 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,525
+8,000 vol $7.07 each |
12,200 | |
Filed 2022-03-10 15:39 Tx date 2022-03-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,028
+4,200 vol $8.34 each |
4,200 | |
Filed 2022-03-10 15:38 Tx date 2021-12-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knudson, Ken
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-03-09 11:49 Tx date 2022-03-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$127,949
+15,000 vol $8.53 each |
348,280 | |
Filed 2022-03-09 08:37 Tx date 2022-03-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$369,449
+45,584 vol $8.10 each |
333,280 | |
Filed 2021-11-09 14:38 Tx date 2021-11-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,387
+8,100 vol $12.39 each |
287,696 | |
Filed 2021-11-01 18:14 Tx date 2021-10-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$228,000
+80,000 vol $2.85 each |
||
Filed 2021-11-01 18:04 Tx date 2021-10-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$228,000
+80,000 vol $2.85 each |
||
Filed 2021-09-08 09:38 Tx date 2021-09-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,004
+535 vol $18.70 each |
1,415 | |
Filed 2021-09-01 10:32 Tx date 2021-08-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$299,993
+32,608 vol $9.20 each |
279,596 | |
Filed 2021-09-01 10:31 Tx date 2021-08-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-299,993.60
-32,608 vol $9.20 each |
457,392 | |
Filed 2021-08-17 09:01 Tx date 2021-08-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,425
+6,500 vol $15.45 each |
6,500 | |
Filed 2021-08-17 08:59 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-06-23 14:06 Tx date 2021-06-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,020
+880 vol $22.75 each |
880 | |
Filed 2021-06-23 14:03 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-26 15:31 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
+100,000 vol |
100,000 | |
Filed 2021-05-26 15:06 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-05-26 10:36 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$681,543
+30,867 vol $22.08 each |
101,700 | |
Filed 2021-05-26 10:35 Tx date 2021-05-19 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Burtnyk, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,833 | ||
Filed 2021-05-26 09:53 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,088,256
+49,287 vol $22.08 each |
490,000 | |
Filed 2021-05-26 09:51 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,137,848
+51,533 vol $22.08 each |
101,700 | |
Filed 2021-05-26 09:48 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$880,241
+39,866 vol $22.08 each |
101,699 | |
Filed 2021-05-26 09:46 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
20,000 | |
Filed 2021-05-26 09:44 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
33,300 | |
Filed 2021-05-26 09:42 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
33,300 | |
Filed 2021-05-26 09:40 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
34,950 | |
Filed 2021-05-26 09:37 Tx date 2021-05-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$220,799
+10,000 vol $22.08 each |
20,000 | |
Filed 2021-05-20 11:43 Tx date 2021-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,000
+3,000 vol $19.00 each |
246,988 | |
Filed 2021-05-20 11:43 Tx date 2021-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,568
+2,000 vol $18.28 each |
243,988 | |
Filed 2021-05-19 14:58 Tx date 2021-05-19 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$319,793
+18,000 vol $17.77 each |
18,000 | |
Filed 2021-05-19 14:54 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-15 09:46 Tx date 2021-03-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$281,600
+10,000 vol $28.16 each |
10,000 | |
Filed 2021-03-15 09:43 Tx date 2021-03-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lavoie, Cynthia Ann
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-09 15:57 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,500
-6,250 vol $22.00 each |
0 | |
Filed 2021-03-09 15:45 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-137,500
-6,250 vol $22.00 each |
||
Filed 2021-03-09 15:45 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-886,032
-31,644 vol $28.00 each |
6,250 | |
Filed 2021-03-09 15:42 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$384,239
+32,289 vol $11.90 each |
102,534 | |
Filed 2021-03-09 15:40 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$54,432
+5,853 vol $9.30 each |
108,387 | |
Filed 2021-03-09 15:40 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$364,182
+39,585 vol $9.20 each |
70,245 | |
Filed 2021-03-09 15:39 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$236,164
+25,394 vol $9.30 each |
37,894 | |
Filed 2021-03-09 15:38 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$38,336
+4,167 vol $9.20 each |
12,500 | |
Filed 2021-03-09 15:38 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$24,787
+2,083 vol $11.90 each |
8,333 | |
Filed 2021-03-09 15:26 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-236,164.20
-25,394 vol $9.30 each |
143,962 | |
Filed 2021-03-09 15:25 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-38,336.40
-4,167 vol $9.20 each |
169,356 | |
Filed 2021-03-09 15:23 Tx date 2021-03-05 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,787.70
-2,083 vol $11.90 each |
173,523 | |
Filed 2020-12-25 12:18 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,432
+5,853 vol $9.30 each |
||
Filed 2020-12-25 12:18 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$384,239
+32,289 vol $11.90 each |
||
Filed 2020-12-25 12:16 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2021-02-09 11:44 Tx date 2021-02-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-87,500
-6,250 vol $14.00 each |
0 | |
Filed 2021-02-09 11:28 Tx date 2021-02-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$87,500
+6,250 vol $14.00 each |
6,250 | |
Filed 2021-02-09 11:26 Tx date 2021-02-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$87,500
+62,500 vol $1.40 each |
||
Filed 2020-12-25 12:27 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,046,975.344
-108,387 vol $28.11 each |
0 | |
Filed 2020-12-25 12:26 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,046,975.344
-108,387 vol $28.11 each |
||
Filed 2020-12-25 12:18 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,432
+5,853 vol $9.30 each |
108,387 | |
Filed 2020-12-25 12:18 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$384,239
+32,289 vol $11.90 each |
102,534 | |
Filed 2020-12-25 12:16 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$364,182
+39,585 vol $9.20 each |
70,245 | |
Filed 2020-12-25 12:07 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-54,432.90
-5,853 vol $9.30 each |
175,606 | |
Filed 2020-12-25 12:07 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-384,239.10
-32,289 vol $11.90 each |
181,459 | |
Filed 2020-12-25 12:05 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-364,182
-39,585 vol $9.20 each |
213,748 | |
Filed 2020-12-25 12:04 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$54,711
+5,883 vol $9.30 each |
||
Filed 2020-12-25 12:04 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$384,239
+32,289 vol $11.90 each |
||
Filed 2020-12-25 12:04 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-25 11:45 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,046,975.344
-108,387 vol $28.11 each |
||
Filed 2020-12-25 11:45 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,046,975.344
-108,387 vol $28.11 each |
-77,727 | |
Filed 2020-12-25 11:43 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$54,711
+5,883 vol $9.30 each |
331,090 | |
Filed 2020-12-25 11:43 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$54,711
+5,883 vol $9.30 each |
||
Filed 2020-12-25 11:42 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$384,239
+32,289 vol $11.90 each |
||
Filed 2020-12-25 11:42 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$384,239
+32,289 vol $11.90 each |
325,207 | |
Filed 2020-12-25 11:40 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-25 11:40 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
292,918 | |
Filed 2020-12-25 11:34 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-25 11:34 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-25 11:32 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-25 11:32 Tx date 2020-12-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$364,182
+39,585 vol $9.20 each |
||
Filed 2020-12-16 14:30 Tx date 2020-12-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$230,200
+10,000 vol $23.02 each |
10,000 | |
Filed 2020-12-16 14:28 Tx date 2020-11-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lortie, Murielle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-06-30 10:53 Tx date 2020-06-29 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$70,000
+5,000 vol $14.00 each |
17,500 | |
Filed 2020-06-30 10:52 Tx date 2020-06-29 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-70,000
-5,000 vol $14.00 each |
0 | |
Filed 2020-06-29 10:21 Tx date 2020-06-26 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$70,000
+5,000 vol $14.00 each |
10,000 | |
Filed 2020-06-29 10:20 Tx date 2020-06-26 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-70,000
-5,000 vol $14.00 each |
2,500 | |
Filed 2020-05-20 14:01 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
20,000 | |
Filed 2020-05-20 13:59 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Maxwell, Evelyn Linda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
23,300 | |
Filed 2020-05-20 13:57 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
24,950 | |
Filed 2020-05-20 13:38 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
23,300 | |
Filed 2020-05-20 13:35 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$174,400
+10,000 vol $17.44 each |
23,300 | |
Filed 2020-05-20 13:22 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$482,512
+27,667 vol $17.44 each |
50,167 | |
Filed 2020-05-20 13:20 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,567
+4,333 vol $17.44 each |
61,833 | |
Filed 2020-05-20 13:18 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$930,127
+53,333 vol $17.44 each |
253,333 | |
Filed 2020-05-20 13:14 Tx date 2020-05-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,719,113
+98,573 vol $17.44 each |
440,713 | |
Filed 2020-01-27 13:25 Tx date 2020-01-27 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,445
+3,300 vol $11.65 each |
30,660 | |
Filed 2020-01-27 13:13 Tx date 2020-01-27 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$38,445
+3,300 vol $11.65 each |
234,488 | |
Filed 2020-01-09 16:08 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-67,500 vol |
7,500 | |
Filed 2020-01-09 16:07 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-202,500 vol |
22,500 | |
Filed 2020-01-09 16:06 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-157,500 vol |
17,500 | |
Filed 2020-01-09 16:04 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-45,000 vol |
5,000 | |
Filed 2020-01-09 16:04 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-517,500 vol |
57,500 | |
Filed 2020-01-09 16:02 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-112,500 vol |
12,500 | |
Filed 2020-01-09 16:00 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-135,000 vol |
15,000 | |
Filed 2020-01-09 15:59 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,288,751 vol |
476,528 | |
Filed 2020-01-09 15:58 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-871,200 vol |
96,800 | |
Filed 2020-01-09 15:56 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
37 - Stock split or consolidation
|
-56,250 vol |
6,250 | |
Filed 2020-01-09 15:55 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,800,000 vol |
200,000 | |
Filed 2020-01-09 15:54 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-246,240 vol |
27,360 | |
Filed 2020-01-09 15:52 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Maxwell, Evelyn Linda
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-29,700 vol |
3,300 | |
Filed 2020-01-09 15:50 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-44,550 vol |
4,950 | |
Filed 2020-01-09 15:48 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-29,700 vol |
3,300 | |
Filed 2020-01-09 15:44 Tx date 2019-10-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-29,700 vol |
3,300 | |
Filed 2020-01-08 12:24 Tx date 2020-01-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,478,268
+134,388 vol $11.00 each |
1,102,388 | |
Filed 2020-01-08 12:22 Tx date 2020-01-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,478,268
-134,388 vol $11.00 each |
4,630,891 | |
Filed 2020-01-02 11:55 Tx date 2019-12-30 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-175,000
-12,500 vol $14.00 each |
162,500 | |
Filed 2019-11-20 11:33 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
10,000 | |
Filed 2019-11-20 11:33 Tx date 2019-08-06 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Forte, Steve
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-20 11:03 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
43,000 | |
Filed 2019-11-20 10:59 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
43,000 | |
Filed 2019-11-20 10:56 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
59,500 | |
Filed 2019-11-20 10:52 Tx date 2019-11-18 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Maxwell, Evelyn Linda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$112,300
+10,000 vol $11.23 each |
43,000 | |
Filed 2019-05-21 13:34 Tx date 2019-05-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,840,000
+2,000,000 vol $0.92 each |
4,765,279 | |
Filed 2019-05-21 13:32 Tx date 2019-05-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,000
+25,000 vol $0.92 each |
225,000 | |
Filed 2019-05-21 13:29 Tx date 2019-05-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$920,000
+1,000,000 vol $0.92 each |
2,000,000 | |
Filed 2019-05-21 13:25 Tx date 2019-05-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,000
+200,000 vol $0.92 each |
575,000 | |
Filed 2019-01-07 Tx date 2019-01-07 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-800,000 vol |
0 | |
Filed 2018-12-04 Tx date 2018-12-03 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,914
+89,700 vol $0.66 each |
904,000 | |
Filed 2018-12-04 Tx date 2018-12-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,910
+64,000 vol $0.69 each |
968,000 | |
Filed 2018-11-22 Tx date 2018-11-19 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Maxwell, Evelyn Linda
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$19,800
+33,000 vol $0.60 each |
33,000 | |
Filed 2018-11-22 Tx date 2018-11-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Maxwell, Evelyn Linda
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-02 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,880
+29,000 vol $0.72 each |
273,600 | |
Filed 2018-10-02 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,800
+15,000 vol $0.72 each |
15,000 | |
Filed 2018-10-02 Tx date 2002-09-27 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,880
+29,000 vol $0.72 each |
||
Filed 2018-10-02 Tx date 2018-05-10 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-01 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,380
+6,000 vol $0.73 each |
273,600 | |
Filed 2018-10-01 Tx date 2002-09-27 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,880
+29,000 vol $0.72 each |
267,600 | |
Filed 2018-09-28 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,800
+15,000 vol $0.72 each |
175,000 | |
Filed 2018-09-28 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$99,009
+137,000 vol $0.72 each |
814,300 | |
Filed 2018-09-28 Tx date 2018-09-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,000
+25,000 vol $0.72 each |
125,000 | |
Filed 2018-08-27 Tx date 2018-08-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$372,000
+400,000 vol $0.93 each |
800,000 | |
Filed 2018-08-27 Tx date 2018-08-23 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$465,000
+500,000 vol $0.93 each |
1,000,000 | |
Filed 2018-06-19 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,660
+33,000 vol $1.02 each |
33,000 | |
Filed 2018-06-19 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rosenthal, Arthur Lee
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,660
+33,000 vol $1.02 each |
33,000 | |
Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,830
+16,500 vol $1.02 each |
49,500 | |
Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Curran, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,830
+16,500 vol $1.02 each |
82,500 | |
Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Ellacott, Brian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-06-18 Tx date 2018-06-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,830
+16,500 vol $1.02 each |
33,000 | |
Filed 2018-05-23 Tx date 2018-05-03 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-23 Tx date 2018-05-10 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-05-23 Tx date 2018-05-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Heynen, Ian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$476,000
+400,000 vol $1.19 each |
400,000 | |
Filed 2018-05-23 Tx date 2018-05-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$595,000
+500,000 vol $1.19 each |
500,000 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+150,000 vol $1.00 each |
677,300 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$105,000
+75,000 vol $1.40 each |
150,000 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$35,000
+25,000 vol $1.40 each |
75,000 | |
Filed 2018-05-09 Tx date 2018-03-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+50,000 vol $1.00 each |
160,000 | |
Filed 2018-05-04 Tx date 2018-05-03 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
238,600 | ||
Filed 2018-05-04 Tx date 2018-05-03 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Davidson, Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
62,500 | ||
Filed 2017-11-21 Tx date 2017-11-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,250
+45,000 vol $0.85 each |
200,000 | |
Filed 2017-11-21 Tx date 2017-11-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knaus, Alexander Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
Filed 2017-11-21 Tx date 2017-08-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Knaus, Alexander Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-21 Tx date 2017-08-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sullivan, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-11-21 Tx date 2017-11-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sullivan, Robert
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
Filed 2017-09-23 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
Filed 2017-09-23 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+150,000 vol $1.00 each |
527,300 | |
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$105,000
+75,000 vol $1.40 each |
75,000 | |
Filed 2017-09-22 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$70,000
+50,000 vol $1.40 each |
50,000 | |
Filed 2017-09-22 Tx date 2015-11-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-09-22 Tx date 2017-09-20 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+100,000 vol $1.00 each |
110,000 | |
Filed 2017-08-01 Tx date 2017-07-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Koninklijke Philips N.V.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$8,140,000
+7,400,000 vol $1.10 each |
7,400,000 | |
Filed 2017-08-01 Tx date 2017-07-31 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Koninklijke Philips N.V.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2017-03-06 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-04-27 Tx date 2017-04-25 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,005
+16,500 vol $0.97 each |
16,500 | |
Filed 2017-04-26 Tx date 2017-04-25 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$32,010
+33,000 vol $0.97 each |
33,000 | |
Filed 2017-04-26 Tx date 2017-04-25 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Curran, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,005
+16,500 vol $0.97 each |
66,000 | |
Filed 2017-04-26 Tx date 2017-01-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Galbraith, Kenneth Harry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-12-28 Tx date 2016-12-28 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,781
+44,300 vol $1.08 each |
377,300 | |
Filed 2016-12-22 Tx date 2016-12-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,559,341
+1,417,583 vol $1.10 each |
||
Filed 2016-12-22 Tx date 2016-12-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,559,341
+1,417,583 vol $1.10 each |
2,765,279 | |
Filed 2016-12-13 Tx date 2016-12-13 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,300
+9,300 vol $1.00 each |
333,000 | |
Filed 2016-12-09 Tx date 2016-12-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,300
+9,300 vol $1.00 each |
323,700 | |
Filed 2016-12-08 Tx date 2016-12-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,900
+3,900 vol $1.00 each |
314,400 | |
Filed 2016-12-05 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,030
+227,300 vol $1.10 each |
227,300 | |
Filed 2016-12-05 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,063
+227,330 vol $1.10 each |
||
Filed 2016-12-02 Tx date 2016-12-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,500
+39,500 vol $1.00 each |
266,830 | |
Filed 2016-12-02 Tx date 2016-12-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,700
+43,700 vol $1.00 each |
310,530 | |
Filed 2016-11-28 Tx date 2016-11-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
$400,555
+364,141 vol $1.10 each |
||
Filed 2016-11-28 Tx date 2016-11-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+75,000 vol $1.10 each |
155,000 | |
Filed 2016-11-28 Tx date 2016-11-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$400,555
+364,141 vol $1.10 each |
1,347,696 | |
Filed 2016-11-19 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventrues III LP (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$2,999,999
+2,727,272 vol $1.10 each |
2,727,272 | |
Filed 2016-11-19 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventrues III LP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-16 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
BDC
3 - 10% Security Holder of Issuer
Holder: BDC Capital Inc. (Control or Direction)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$3,999,999
+3,636,363 vol $1.10 each |
13,441,792 | |
Filed 2016-11-15 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-11-15 Tx date 2016-11-14 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$250,063
+227,330 vol $1.10 each |
227,330 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Curran, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,770
+16,500 vol $1.38 each |
||
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,275
+16,500 vol $1.35 each |
983,555 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Curran, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,275
+16,500 vol $1.35 each |
49,500 | |
Filed 2016-09-20 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,275
+16,500 vol $1.35 each |
16,500 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,550
+33,000 vol $1.35 each |
49,500 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,770
+16,500 vol $1.38 each |
||
Filed 2016-09-16 Tx date 2016-09-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$22,770
+16,500 vol $1.38 each |
983,555 | |
Filed 2016-08-23 Tx date 2016-08-22 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,363,720
+934,055 vol $1.46 each |
967,055 | |
Filed 2016-07-20 Tx date 2016-07-19 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$67,500
+50,000 vol $1.35 each |
80,000 | |
Filed 2016-06-29 Tx date 2016-06-29 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$725.00
+500 vol $1.45 each |
6,500 | |
Filed 2016-06-21 Tx date 2016-06-21 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$750.00
+500 vol $1.50 each |
6,000 | |
Filed 2015-12-24 Tx date 2015-12-24 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$460.00
+500 vol $0.92 each |
5,500 | |
Filed 2015-12-18 Tx date 2015-12-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$910.00
+1,000 vol $0.91 each |
5,000 | |
Filed 2015-12-16 Tx date 2015-12-15 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,184
+1,600 vol $0.74 each |
4,000 | |
Filed 2015-12-10 Tx date 2015-11-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-12-10 Tx date 2015-12-09 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+10,000 vol $0.72 each |
10,000 | |
Filed 2015-12-02 Tx date 2015-12-02 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$850.00
+1,000 vol $0.85 each |
2,400 | |
Filed 2015-11-23 Tx date 2015-11-17 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Dewan, Rashed Osman
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
Filed 2015-09-16 Tx date 2015-09-16 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,700
+3,000 vol $0.90 each |
10,000 | |
Filed 2015-09-13 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-09-13 Tx date 2015-09-11 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,440
+7,000 vol $0.92 each |
7,000 | |
Filed 2015-09-11 Tx date 2015-09-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+300,000 vol $1.50 each |
||
Filed 2015-09-11 Tx date 2015-09-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$450,000
+300,000 vol $1.50 each |
375,000 | |
Filed 2015-09-11 Tx date 2015-09-08 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Kurtz, Ronald Leon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$337,500
+225,000 vol $1.50 each |
375,000 | |
Filed 2015-09-01 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Kurtz, Ronald Leon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-09-01 Tx date 2015-09-01 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Kurtz, Ronald Leon
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,950
+5,000 vol $0.99 each |
5,000 | |
Filed 2015-06-29 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-29 Tx date 2015-06-25 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,959
+1,400 vol $1.40 each |
1,400 | |
Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+33,000 vol |
33,000 | |
Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Menawat, Dr., Arun
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-14 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Goodman, Jonathan Ross
4 - Director of Issuer
Holder: Knight Therapeutics Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,050,850 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Lamb, Damian Peter
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Genesys Ventures II L.P, (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,100,872 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Kurtz, Ronald Leon
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
150,000 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Singh, Guruprit Kour
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Genesys Ventures II L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
9,100,872 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Curran, William Edward
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
33,000 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Rampertab, Shameze
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
403,283 | ||
Filed 2015-06-12 Tx date 2015-06-04 |
$PRN
Profound Medical Corp. (formerly Mira IV Acquisition Corp.) |
Plymale, Steven
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,793,143 |